Published trade mark details for 2238739
This information was published on 2024-10-12T03:38:52 for Full Assignment - Subsequent Owner Registered Published.
| Field | Value |
| (210) | 2238739 (IR 1635072) |
| (220) |
17 Nov 2021
|
| (300) |
EM, 05 Nov 2021, 018594225
|
| (500) |
Blue, magenta and green.
Following a communication from the holder, Amryt Research Limited, the International Bureau has been informed that the holder's right of disposal of the above-mentioned international registrations has been restricted in all the designated Contracting Parties, following the execution of a Debenture, dated 18 February 2022, in favour of Ares Capital Corporation. Blue, magenta and green. Following a communication from the representative, Best Rechtsanwälte, dated 13 June 2023, the International Bureau has been informed that the restriction of the holder's right of disposal of the above-mentioned international registrations, in all the designated Contracting Parties, has to be removed. Under the terms of a Trademark Release dated 13 April 2023, Ares Capital Corporation has terminated and released the Debenture dated 18 February 2022, including the entirety of its security interests granted therein, including the international trademarks identified in the table above. The Trademark Release states: "Grantee hereby terminates, releases and discharges its continuing security interest in and liens on Grantors' entire right, title and interest in and to and under the United States Trademark registrations and Trademark applications listed on Annex II attached hereto, together with (a) all renewals or extensions thereof". The applicant has advised that the words in the Mark have no meaning in English |
| (511) (510) |
Class 5
Topical gels for medical and therapeutic use; topical gel for medical and therapeutic treatment of epidermolysis bullosa; pharmaceutical preparations; pharmaceutical preparations for the treatment of epidermolysis bullosa; dermatological pharmaceutical products; medicated skin care preparations. |
| (540) |
|
| (550) | Figurative |
| (730) |
Amryt Pharmaceuticals DAC
|
Find out more about publications on the About page.